Imaging Contrast

Contrast agents are injected into patients to help enhance images to make it easier for radiologists distinguish specific areas of the body from surrounding tissues. The most commonly used agents are iodinated contrast dye for computed tomography (CT), interventional cath lab angiography,  RF fluoroscopy, and in surgical OR procedures. MRI scans typically use gadolinium-based contrast agents. Ultrasound and echocardiography (cardiac ultrasound) imaging use contrast agents composed of microscopic bubbles to enhance images that otherwise would be suboptimal.

RSS icon
Video of David Hur discussing how to overcome technical challenges in cardiac CT, which he presented on in sessions at SCCT 2023.

Overcoming technical challenges in cardiac CT

David Hur, MD, director of structural heart disease/interventional imaging at the VA Connecticut Healthcare System, and an assistant professor of medicine at Yale, explains the technical challenges encountered in cardiac computed tomography (CT) and how to overcome them.

liver cancer

Targeted training reduces certain radiologist errors when reading contrast-enhanced CT

Physicians can sometimes overlook low-contrast lesions, such as hepatic metastases or pancreatic adenocarcinoma, on computed tomography scans. 

Thumbnail

How the 2022 contrast media shortage impacted stroke care

A team of specialists tracked CT utilization before, during and after the 2022 shortage, sharing its findings in the American Journal of Neuroradiology.

Thumbnail

Generic substitute for gadolinium-based contrast agent Gadavist hits the market

The contrast agent, simply called Gadobutrol Injection, has been approved by the U.S. Food and Drug Administration and is now available in the United States.

Rethinking ICM storage could help imaging departments reduce waste by 59%

“While drug pricing is not opaque and absolute costs of medications can vary widely, any waste comes at a cost," researchers wrote in a new analysis. 

Thumbnail

PROMISE trial results reinforce confidence in new MRI contrast agent

The randomized, double-blinded phase 3 study revealed gadopiclenol to be noninferior to gadobutrol for all qualitative visualization parameters as rated by all blinded readers involved in the trial.

Thumbnail

New discovery paves the way for copper's entrance into MRI contrast agents

The new discovery contradicts the notion that copper is not suitable for use in contrast media.

Syringeless contrast media injectors like the GE Ulrich CT Motion have gained a lot of interest in 2022 because of the iodine contrast shortage. These systems use rollers to squeeze precise amounts of contrast from a large bolus container for multiple patients, helping conserve a significant amount of contrast.

Multi-use syringeless injectors could completely eliminate contrast waste

Such products could increase departmental efficiency and advance environmental initiatives in radiology, experts claimed in Academic Radiology.

Displaying 33 - 40 of 155

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.